Skip to main content
ImmuneCited

Pediatric vitiligo.

Nanette B Silverberg
Review Pediatric clinics of North America 2014 25 atıf
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D24636650'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Çalışma Türü
Review
Popülasyon
Children with vitiligo
Müdahale
Pediatric vitiligo. None
Karşılaştırıcı
None
Birincil Sonuç
Pediatric vitiligo management
Etki Yönü
Positive
Yanlılık Riski
Unclear

Abstract

Vitiligo is a disease of pigment loss. Most investigators currently consider vitiligo to be a disorder that occurs as a result of autoimmune destruction of melanocytes, supported by identification of antimelanocyte antibodies in many patients, and the presence of comorbid autoimmune disease in patients with and family members of individuals with vitiligo. One-half of vitiligo cases are of childhood onset. This article presents a current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations.

Kısaca

A current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations is presented.

Used In Evidence Reviews

Similar Papers